Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal

Fertility and Sterility

Volumn 77, Issue 1, 2002, Pages 128-135

  Sites, Cynthia K ^a,b   Toth, Michael J ^a   Cushman, Mary ^a   L'Hommedieu, Georgia D ^a   Tchernof, André ^a   Tracy, Russell P ^a   Poehlman, Eric T ^a  

^a Department of Obstetrics and Gynecology ^*  (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Body composition; Body fat distribution; C reactive protein; Inflammation; Insulin resistance; Interleukin 6; Menopause; Tumor necrosis factor

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CARDIOVASCULAR RISK; CLAMP; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INFLAMMATION; INSULIN; INTERLEUKIN-6; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036153232     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)02934-X     Document Type: Article

References (29)

1. Hormone replacement therapy: Cardiovascular benefits for aging women
2. Effect of menopausal status on body composition and abdominal fat distribution
3. Changes in energy balance and body composition at menopause: A controlled longitudinal study
4. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
5. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
6. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
7. The expression of TNFα by human muscle: Relationship to insulin resistance
8. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators
9. Regulation of TNF-alpha production in activated mouse macrophages by progesterone
10. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
11. Postmenopausal changes in serum cytokine levels and hormone replacement therapy
12. Elevated C-reactive protein levels in overweight and obese adults
13. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity
14. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial function
15. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
16. Association of serum tumour necrosis factor-α with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women
17. Effect of menopausal status on insulin-stimulated glucose disposal: Comparison of middle-aged premenopausal and early postmenopausal women
18. Hormonal and physiologic correlates of energy expenditure and substrate oxidation in middle-aged, premenopausal women
19. Sex hormone-binding globulin levels in middle-aged premenopausal women: Associations with visceral obesity and metabolic profile
20. Regulation of protein metabolism in middle-aged, premenopausal women: Roles of adiposity and estradiol
21. Relation of regional fat distribution to insulin sensitivity in postmenopausal women
22. Glucose clamp technique: A method for quantifying insulin secretion and resistance
23. Variability in the measurement of C-reactive protein in healthy subjects: Implication for reference interval and epidemiologic applications
24. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
25. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol and pentoxifylline
26. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
27. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: A population-based study
28. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) study
29. Hormone replacement therapy and increased plasma concentration of C-reactive protein